Citalopram Hydrobromide
Product Images NDC 66116-353

2 FDA label images from Medvantx, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Citalopram Hydrobromide (NDC 66116-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (9171c747 D032 4732 B067 17cd9c77357a 01)

Structure (9171c747 D032 4732 B067 17cd9c77357a 01)
Chemical structure of Citalopram Hydrobromide, showing the molecular arrangement of atoms including cyano, fluoro, and dimethylamino groups with a hydrobromide moiety.*
FDA Label Image

Citalopram 40mg Tablets W/insert #15 (9171c747 D032 4732 B067 17cd9c77357a 02)

Citalopram 40mg Tablets W/insert #15 (9171c747 D032 4732 B067 17cd9c77357a 02)
Label for Citalopram Tablets USP 40 mg, supplied by MedVantx, Inc. The bottle contains 15 tablets with instructions to see package insert for dosage. The label includes storage conditions, manufacturer Dr. Reddy's Labs Ltd., and contact information for MedVantx, Inc. This is a sample, not for sale, prescription-only medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.